Arcus Biosciences, Inc. (RCUS) Operating cash flow 2016–2025
Arcus Biosciences, Inc. (RCUS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$482.0MFY2025 · since FY2016: -$12.9M → -$482.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$482.0M | -183.5% |
| FY2024 | -$170.0M | +44.4% |
| FY2023 | -$306.0M | -169.9% |
| FY2022 | $438.0M | +271.1% |
| FY2021 | -$256.0M | -330.6% |
| FY2020 | $111.0M | +251.1% |
| FY2019 | -$73.5M | -70.9% |
| FY2018 | -$43.0M | -71.6% |
| FY2017 | -$25.1M | -93.6% |
| FY2016 | -$12.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RCUS financial trends
RCUS RevenueRCUS Net incomeRCUS Net marginRCUS Gross profitRCUS Gross marginRCUS Operating incomeRCUS Operating marginRCUS Free cash flowRCUS Capital expendituresRCUS Return on equityRCUS Stock buybacksRCUS Dividends paidRCUS Total assetsRCUS Total liabilitiesRCUS Shareholders’ equityRCUS overview →